SMTL ID : 3wze.1

KDR in complex with ligand sorafenib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x BAX: 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE(Non-covalent)

BAX.1: 22 residues within 4Å: Chain A: L.27, V.35, A.53, K.55, E.72, L.76, I.79, V.85, V.86, V.103, E.104, F.105, C.106, K.107, G.109, L.156, H.163, L.172, I.181, C.182, D.183, F.184 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:V.35, A:A.53, A:K.55, A:E.72, A:L.76, A:V.103, A:L.172, A:F.184, A:F.184 Hydrogen bonds: A:K.55, A:E.72, A:E.72, A:C.106, A:C.106, A:G.109, A:D.183 Halogen bonds: A:I.181

1 x ACT: ACETATE ION(Non-functional Binders)

ACT.2: 4 residues within 4Å: Chain A: C.144, Q.148, K.176, N.177 No protein-ligand interaction detected (PLIP)

1 x DTT: 2,3-DIHYDROXY-1,4-DITHIOBUTANE(Non-covalent)

DTT.3: 5 residues within 4Å: Chain A: K.22, D.39, A.40, F.41, C.49 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Okamoto, K. et al., Distinct binding mode of multikinase inhibitor lenvatinib revealed by biochemical characterization. ACS MED.CHEM.LETT. (2015)

Release Date

2015-05-27

Peptides

Vascular endothelial growth factor receptor 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Vascular endothelial growth factor receptor 2

Related Entries With Identical Sequence